The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk ...
This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.
The University of New Haven announced today that the Kingdom of Saudi Arabia’s Council of Ministers has approved its plans to establish a branch campus in Riyadh, which is set to open in Fall 2026.